List of X4 Pharmaceuticals patents | 8 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11672793 Compositions of CXCR4 inhibitors and methods of preparation and use	Patent 11672793 was granted and assigned to X4 Pharmaceuticals on June, 2023 by the United States Patent and Trademark Office.	X4 Pharmaceuticals	X4 Pharmaceuticals	United States Patent and Trademark Office	11672793	June 13, 2023
‌ US Patent 10548889 Compositions of CXCR4 inhibitors and methods of preparation and use	Patent 10548889 was granted and assigned to X4 Pharmaceuticals on February, 2020 by the United States Patent and Trademark Office.	X4 Pharmaceuticals	X4 Pharmaceuticals	United States Patent and Trademark Office	10548889	February 4, 2020
‌ US Patent 11045461 Compositions of CXCR4 inhibitors and methods of preparation and use	Patent 11045461 was granted and assigned to X4 Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.	X4 Pharmaceuticals	X4 Pharmaceuticals	United States Patent and Trademark Office	11045461	June 29, 2021
‌ US Patent 10610527 Methods for treating immunodeficiency disease	Patent 10610527 was granted and assigned to X4 Pharmaceuticals on April, 2020 by the United States Patent and Trademark Office.	X4 Pharmaceuticals	X4 Pharmaceuticals	United States Patent and Trademark Office	10610527	April 7, 2020
‌ US Patent 10759796 CXCR4 inhibitors and uses thereof	Patent 10759796 was granted and assigned to X4 Pharmaceuticals on September, 2020 by the United States Patent and Trademark Office.	X4 Pharmaceuticals	X4 Pharmaceuticals	United States Patent and Trademark Office	10759796	September 1, 2020
‌ US Patent 10988465 CXCR4 inhibitors and uses thereof	Patent 10988465 was granted and assigned to X4 Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.	X4 Pharmaceuticals	X4 Pharmaceuticals	United States Patent and Trademark Office	10988465	April 27, 2021
‌ US Patent 11780837 CXCR4 inhibitors and uses thereof	Patent 11780837 was granted and assigned to X4 Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.	X4 Pharmaceuticals	X4 Pharmaceuticals	United States Patent and Trademark Office	11780837	October 10, 2023
‌ US Patent 12115156 Compositions of CXCR4 inhibitors and methods of preparation and use	Patent 12115156 was granted and assigned to X4 Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office.	X4 Pharmaceuticals	X4 Pharmaceuticals	United States Patent and Trademark Office	12115156	October 15, 2024